Literature DB >> 2412033

The acute antihypertensive effect of ketanserin increases with age.

J De Crée, M Hoing, M De Ryck, J Symoens.   

Abstract

The relationship between the acute blood pressure lowering effect of ketanserin with age was investigated in 57 patients ranging from 25 to 90 years (mean 61 years). There was a highly significant correlation between the degree of reduction of systolic and diastolic blood pressure and age, independent of the starting blood pressure. The fact that the acute blood pressure-lowering effect of ketanserin increases with age may suggest a role for serotonin in blood pressure regulation, particularly in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412033     DOI: 10.1097/00005344-198500077-00037

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

Review 1.  The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of ketanserin.

Authors:  B Persson; J Heykants; T Hedner
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 3.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  Responders and non-responders to antihypertensive treatment.

Authors:  C J Bulpitt
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Comparison of ketanserin with captopril in older hypertensives. A double-blind randomised trial.

Authors:  P Meyer; M Safar
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Ageing, serotonin and ketanserin.

Authors:  A Breckenridge
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Antihypertensive effect of long term ketanserin in elderly essential hypertensive patients. Assessment of left ventricular function at rest and during exercise.

Authors:  R A Sánchez; F Otero; A J Ramírez; O Degrossi; J Glenny; E J Marcó
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Arterial dilatation and venous constriction induced by serotonin in the elderly.

Authors:  G J Blauw; P van Brummelen; P C Chang; P Vermeij; P A van Zwieten
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.

Authors:  J Heykants; A Van Peer; R Woestenborghs; S Gould; J Mills
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Pharmacokinetics of ketanserin in patients with essential hypertension.

Authors:  B Persson; A Pettersson; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.